Glimpse Group insider awarded new stock options

Glimpse Group, Inc. reported that former director Alexander Ruckdaeschel received two stock option awards linked to the company’s common stock.

Rhea-AI Filing Summary

Glimpse Group, Inc. reported that former director Alexander Ruckdaeschel received two stock option awards linked to the company’s common stock. On 1 January 2025, he was granted options for 37,500 shares with an exercise price of $2.25 per share, vesting in equal monthly increments from 31 January 2025 through 31 December 2025.

On 1 May 2026, he received an additional grant of options for 60,417 shares with an exercise price of $0.69 per share, which vested immediately upon grant. Both option series are scheduled to expire on 31 May 2031. The filing does not report any corresponding stock sales or exercises.

Insider Trade Summary

Grant/Award: 97,917 shares

Grant/Award 2 txns

Insider RUCKDAESCHEL ALEXANDER

Role Insider

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F2	60,417	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) F1	37,500	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 97,917 contracts (Direct)

Footnotes (2)

1. F1. This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.
2. F2. This option vested immediately upon grant.

Key Figures

Option grant size: 37,500 shares Exercise price: $2.25 per share Option grant size: 60,417 shares +3 more

6 metrics

Option grant size 37,500 shares Stock options granted 1 January 2025 to purchase common stock

Exercise price $2.25 per share Strike price for 37,500-share option grant dated 1 January 2025

Option grant size 60,417 shares Stock options granted 1 May 2026 to purchase common stock

Exercise price $0.69 per share Strike price for 60,417-share option grant dated 1 May 2026

Option expiration date 31 May 2031 Expiration date for both reported option grants

Vesting period Jan 31, 2025 – Dec 31, 2025 Monthly vesting schedule for 37,500-share option grant

Key Terms

Stock Option (Right to Buy), exercise price, vesting, Rule 10b5-1

4 terms

Stock Option (Right to Buy) financial

"Security title reported as "Stock Option (Right to Buy)" for both grants."

exercise price financial

"Each option grant specifies an exercise price per share of common stock."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"One option vested monthly in 2025, another vested immediately upon grant."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Rule 10b5-1 regulatory

"The Rule 10b5-1 checkbox is present but not marked as a trading plan."

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock options did Alexander Ruckdaeschel receive from Glimpse Group (GGRP)?

Alexander Ruckdaeschel received two option grants covering 37,500 and 60,417 shares of Glimpse Group common stock. The grants were awarded in January 2025 and May 2026 as compensation-related stock options, not open-market share purchases.

What are the exercise prices of the new GGRP options reported for Alexander Ruckdaeschel?

The reported options have exercise prices of $2.25 and $0.69 per share. The 37,500-share grant carries the $2.25 strike, while the 60,417-share grant is exercisable at $0.69 per share, both tied to Glimpse Group common stock.

How do the vesting schedules differ for Alexander Ruckdaeschel’s GGRP option grants?

The 37,500-share option grant vested in equal monthly installments from 31 January 2025 through 31 December 2025. The 60,417-share option grant vested immediately upon grant on 1 May 2026, according to the reported footnotes.

When do Alexander Ruckdaeschel’s Glimpse Group (GGRP) stock options expire?

Both reported option grants are scheduled to expire on 31 May 2031. This single expiration date applies to the 37,500-share grant at $2.25 per share and the 60,417-share grant at $0.69 per share, if not exercised earlier.

Did the GGRP Form 4 show any stock sales or exercises by Alexander Ruckdaeschel?

The Form 4 reports awards of stock options but no common stock sales or option exercises. Both transactions use code “A,” indicating grant or award acquisitions of derivative securities rather than market purchases or disposals of Glimpse Group shares.

Were Alexander Ruckdaeschel’s GGRP option grants under a Rule 10b5-1 trading plan?

The Form 4’s Rule 10b5-1 checkbox is not marked as being pursuant to such a plan, and the footnotes do not reference any trading plan. The filing therefore presents the option awards as standard compensation-related grants, not pre-planned trading transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 04:40 PM Accepted by SEC EDGAR 07/30/2026 - 04:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RUCKDAESCHEL ALEXANDER

(Last) (First) (Middle)

15 WEST 38TH ST

12TH FLOOR

(Street)

NEW YORK NEW YORK 10018

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Glimpse Group, Inc. [ GGRP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Former director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.25	01/01/2025		A		37,500		(1)	05/31/2031	Common Stock	37,500	$0	37,500	D
Stock Option (Right to Buy)	$0.69	05/01/2026		A		60,417		(2)	05/31/2031	Common Stock	60,417	$0	60,417	D

Explanation of Responses:

1. This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.

2. This option vested immediately upon grant.

	/s/ Alexander Ruckdaeschel	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)